What can we learn from Ibrahim's case?
Suspect early to prevent mortality3,14,15
Invasive aspergillosis in ICU patients can be
challenging to diagnose, and diagnostic delays
are associated with increased mortality.14 By
being aware of possible risk factors for IFIs, and
considering Aspergillus in critically ill patients,
including those with ARDS, physicians may be
able to identify this serious complication earlier
and improve outcomes.3
When treating IFIs in the ICU: Treat
promptly, treat broad
Early initiation of appropriate antifungal therapy
is a major determinant of survival in patients with
an IFI.15 In highly immunocompromised patients,
Liposomal Amphotericin B has been shown to
achieve a response rate of 50% (n=107), based
on clinical, radiological and (if available)
microbiological findings.8
Use Liposomal Amphotericin B in a
variety of eligible at-risk patient
populations.6,8,9,16–23
Suspect early to prevent mortality3,14,15
When treating IFIs in the ICU: Treat promptly, treat broad
Invasive aspergillosis in ICU patients can be challenging to diagnose, and diagnostic delays are associated with increased
mortality.14 By being aware of possible risk factors for IFIs, and considering Aspergillus in critically ill patients, including those
with ARDS, physicians may be able to identify this serious complication earlier and improve outcomes.3
Early initiation of appropriate antifungal therapy is a major determinant of survival in patients with an IFI.15 In highly
immunocompromised patients, Liposomal Amphotericin B has been shown to achieve a response rate of 50% (n=107),
based on clinical, radiological and (if available) microbiological findings.8
What can we learn from Ibrahim's case?
Use Liposomal Amphotericin B in a variety of eligible at-risk patient populations.6,8,9,16–23